Stage 2 · Toolkit 2.3
Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Toxicology Study Planning & Management.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Toxicology Study Management SOP
- Toxicology Protocol Review Checklist
- Toxicology Report Review Checklist
- Dose Selection Rationale Template
- Toxicology Study Result Summary Template
- Toxicology Key Finding Summary
- Toxicology Go / No-Go Decision Memo
Excel workbooks
- Toxicology Study Tracker
- Dose Selection Tracker
- Toxicology Finding Tracker
- NOAEL / Exposure Margin Tracker
- Source Data Reference Log
- Toxicology Evidence Matrix
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.4Safety Pharmacology Program
Assess safety pharmacology risks, including cardiovascular, respiratory, and CNS risk.